2022
Sclerotherapy Improves Symptoms in Patients with Small and Moderate Diameter Low-Flow Vascular Malformations: A Prospective Cohort Study
Leal B, Procópio R, Dardik A, Navarro T. Sclerotherapy Improves Symptoms in Patients with Small and Moderate Diameter Low-Flow Vascular Malformations: A Prospective Cohort Study. Annals Of Vascular Surgery 2022, 89: 68-77. PMID: 37466046, DOI: 10.1016/j.avsg.2022.09.051.Peer-Reviewed Original ResearchConceptsLow-flow vascular malformationsProspective cohort studyVascular malformationsLarger diameter lesionsQuality of lifeCohort studySymptom improvementPolidocanol foamFunctional limitationsFlow vascular malformationsPolidocanol foam sclerotherapyCommon clinical presentationOptimal patient selectionPatient-reported qualitySessions of sclerotherapyVisual analog scaleHospital das ClínicasDiameter lesionsCent of lesionsMean followRecurrent symptomsSymptom recurrenceClinical responseMost patientsCommon complication
2008
Periprocedural Drug Therapy in Carotid Artery Stenting: The Need for More Evidence
Gortler D, Schlösser FJ, Muhs BE, Nelson MA, Dardik† A. Periprocedural Drug Therapy in Carotid Artery Stenting: The Need for More Evidence. Vascular 2008, 16: 303-309. PMID: 19344586, DOI: 10.2310/6670.2008.00081.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCarotid endarterectomyLarge prospective cohort studyDual antiplatelet therapyProspective cohort studyCarotid artery stentingCohort studyArtery stentingPeriprocedural settingDrug therapyPharmacologic agentsCarotid arteryHigh riskPatient careTherapyOptimal outcomesRegimenGood validityPatientsMore evidenceOutcomesOptimal timeClopidogrelEndarterectomyMedicationsStenting